Accelerate Diagnostics (AXDX) Misses Q2 EPS by 50c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts AXDX Hot Sheet
Join SI Premium – FREE
Accelerate Diagnostics (NASDAQ: AXDX) reported Q2 EPS of ($0.50). Revenue for the quarter came in at $3 million.
For earnings history and earnings-related data on Accelerate Diagnostics (AXDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Reiterates Market Perform Rating on Dine Brands (DIN)
- RBC Capital on Primo Brands Corp. (PRMB): 'Valuation Looks Increasingly Disconnected from Reality'
- Goldman Sachs Downgrades United Overseas Bank Ltd. (UOB:SP) (UOVEY) to Sell
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
